Sarepta Therapeutics
SRPT
SRPT
409 hedge funds and large institutions have $10.2B invested in Sarepta Therapeutics in 2022 Q4 according to their latest regulatory filings, with 84 funds opening new positions, 125 increasing their positions, 127 reducing their positions, and 41 closing their positions.
Holders
409
Holders Change
+36
Holders Change %
+9.65%
% of All Funds
6.6%
Holding in Top 10
13
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+30%
% of All Funds
0.21%
New
84
Increased
125
Reduced
127
Closed
41
Calls
$371M
Puts
$246M
Net Calls
+$125M
Net Calls Change
+$15.9M
Top Buyers
Top Sellers
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
PSC
451
Portman Square Capital
London,
United Kingdom
| – | – | – | – |
|
|
HT
452
HAP Trading
New York
| – | – | – | – |
|
453
Nomura Asset Management
Tokyo,
Japan
| – | – | – | – |
|
|
EF
454
Empowered Funds
Havertown,
Pennsylvania
| – | – | – | – |
|
|
CS
455
Clear Street
New York
| – | – | – | – |
|
456
Simplex Trading
Chicago,
Illinois
| – | – | – | – |
|
457
IMC Chicago
Chicago,
Illinois
| – | – | – | – |
|
|
WAM
458
Wolverine Asset Management
Chicago,
Illinois
| – | – | – | – |
|
|
PVI
459
Pura Vida Investments
New York
| – | – | – | – |
|
|
PI
460
PEAK6 Investments
Chicago,
Illinois
| – | – | – | – |
|
461
Parallax Volatility Advisers
San Francisco,
California
| – | – | – | – |
|